Poseida Therapeutics, Inc.
6 clinical trials · Sponsor
◉ Watch Poseida Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies (NCT06014762) | Poseida Therapeutics, Inc. | 2024-04-16 |
| P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma (NCT04960579) | Poseida Therapeutics, Inc. | 2022-05-05 |
| P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) (NCT04249947) | Poseida Therapeutics, Inc. | 2020-02-28 |
| Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101 (NCT03741127) | Poseida Therapeutics, Inc. | 2018-10-29 |
| P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM) (NCT03288493) | Poseida Therapeutics, Inc. | 2017-09-20 |
Track Poseida Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.